VCEL News and Press, Vericel Corporation From 02/15/24

CAMBRIDGE, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that it will report its fourth-quarter and full-year 2023 financial results on Thursday, February 29, 2024. V...

2024-02-13 13:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

CAMBRIDGE, Mass., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO will present at the Canaccord Genuity Musculoskeletal Conference. The ...

2024-02-02 21:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-01-26 13:17:16 ET More on Vera Therapeutics Vera Therapeutics: Soaring On IgAN Data, But Full Approval A Distant Prospect Vera hits 52-week high after long-term data for lead asset (update) Vera gains as Jefferies upgrades to Buy on lead asset Seeking Al...

2024-01-25 14:44:09 ET More on Vericel MediWound wins DoD funding to develop NexoBrid for U.S. Army Vericel Corporation (VCEL) Q3 2023 Earnings Call Transcript Vericel Corporation 2023 Q3 - Results - Earnings Call Presentation Seeking Alpha’s Quant Rat...

2024-01-09 08:12:53 ET More on Vericel Vericel Corporation (VCEL) Q3 2023 Earnings Call Transcript Vericel Corporation 2023 Q3 - Results - Earnings Call Presentation MediWound wins DoD funding to develop NexoBrid for U.S. Army Seeking Alpha’s Quant Rat...

Full-Year Total Revenue Expected to be Approximately $197.5 Million, Representing 20% Growth, with Fourth Quarter Revenue Growth of 23% to $65 Million MACI Full-Year Revenue Expected to be Approximately $164.8 Million, Representing 25% Growth, with Fourth Quarter Revenue Growth of 22% t...

CAMBRIDGE, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO will present at the 42 nd Annual J.P. Morgan Healthcare Conference...

2023-12-28 23:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...